NSI-189 Phosphate – Powder, 1g

$24.99

  • NSI-189 Phosphate – Powder, 1g is a high-purity laboratory-grade research neurogenic compound in white crystalline powder form, functioning as the phosphate salt of NSI-189 (NeuralStem Inc-189, Amdiglurax, ALTO-100, (4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone;phosphoric acid) with neurogenesis stimulation, antidepressant (non-monoamine based), procognitive, synaptoplastic, and neurotrophic effects that promotes proliferation and differentiation of neural stem/progenitor cells, stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro and in murine hippocampus in vivo with regionally specific effects largely in subventricular zone of hippocampus, increases hippocampal volume, exhibits antidepressant effects mitigating depressive symptoms and improving cognitive function in adults with DSM-5-defined Major Depressive Disorder (MDD), has half-life of approximately 20 hours with typical dose 40-120 mg/day (optimal 40mg once or twice daily for 28 days, no significant improvement at 120mg/day), is a novel multi-domain neurogenic compound with brain-therapeutic properties and potential therapeutic applications across disparate psychiatric disorders including depression, bipolar depression, and cognition, has been studied in phase 1b placebo-controlled double-blind trial (24 MDD patients, 28 days, 40mg/80mg/120mg per day showing positive changes during drug period and follow-up with no side effects at lower doses), and phase 2 study evaluating oral NSI-189 phosphate as monotherapy in major depressive disorder, available for fast, compliant shipping to all U.S. states and European countries.

    • 99.95% purity verified with batch-to-batch consistency certificates of analysis for absolute transparency

    • Formulation completely free of adulterants, excipients, and flow agents – 100% raw chemical ingredient

    • Crystalline powder grade with 99.95% purity validated by analytical testing

    • Glass jar with tamper-proof seal engineered for safe international transit and cool dry place storage minimizing open air contact

Category:
Description

Main Description

NSI-189 Phosphate – Powder, 1g

This premium laboratory-grade research neurogenic compound is supplied as ultra-pure white crystalline powder engineered for modern scientific investigations requiring precise neurogenic small molecule pharmacology and neurogenesis/antidepressant research. NSI-189 Phosphate is the phosphate salt form of NSI-189 (NeuralStem Inc-189, Amdiglurax, ALTO-100, NSI-189 Free Base), a benzylpiperizine-aminiopyridine novel chemical entity developed by Neuralstem for treatment of cognitive disorders and major depressive disorder, with neurogenesis stimulation, antidepressant (non-monoamine based), procognitive, synaptoplastic, and neurotrophic effects that promotes proliferation and differentiation of neural stem/progenitor cells, stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro and stimulates neurogenesis in murine hippocampus in vivo with regionally specific effects observed largely in subventricular zone of hippocampus, increases hippocampal volume, exhibits antidepressant effects mitigating depressive symptoms and improving cognitive function in adults with DSM-5-defined Major Depressive Disorder (MDD), is a novel multi-domain neurogenic compound with brain-therapeutic properties with potential therapeutic applications across disparate psychiatric disorders including depression, bipolar depression, and cognition, has half-life of approximately 20 hours with typical dose 40-120 mg/day (optimal 40mg once or twice daily for 28 days, no significant improvement at 120mg/day), was studied in phase 1b placebo-controlled double-blind trial in 24 MDD patients for 28 days using 40mg/80mg/120mg per day showing over-round positive changes during drug taken period and in follow up days with no side effects at lower doses but no significant improvement at 120mg/day, and phase 2 study evaluating oral NSI-189 phosphate as monotherapy in major depressive disorder, making it a valuable tool for in vitro/in vivo modeling of neurogenesis stimulation, antidepressant research, major depressive disorder, multi-domain psychiatric disorders, neurotrophic pathway modulation, hippocampal volume enhancement, cognition improvement, procognitive effects, synaptoplastic effects, and neurogenic small molecule pharmacology research.

All domestic orders ship directly from primary United States production facilities, ensuring rapid delivery to all 50 U.S. states. International orders to the UK and continental Europe are fulfilled through our dedicated United Kingdom shipping hub, enabling seamless, efficient customs clearance across European borders without delay.

  • Batch-coded containers with publicly accessible lab reports verifying specification 99.95% purity for absolute transparency (may vary between batches)

  • Formulation completely free of adulterants, excipients, and flow agents to guarantee raw chemical purity

  • Strategic crystallization stabilizes compound structure for long-term storage and maintains integrity during transit

  • Packaging engineering utilizes a glass jar with tamper-proof seal to maintain powder stability during transit and cool dry place storage minimizing contact with open air


Technical Specifications & Chemical Profile

Chemical Property Specification Data
Product Name NSI-189 Phosphate – Powder, 1g
Common Synonyms NSI-189 Phosphate, NeuralStem Inc-189 Phosphate, Amdiglurax Phosphate, ALTO-100 Phosphate, (4-benzylpiperazine-1-yl)-[2-(3-methylbutylamino)pyridine-3-yl]methanone;phosphoric acid, NSI-189 phosphate salt, neurogenic compound, benzylpiperizine-aminiopyridine, novel chemical entity, antidepressant compound, procognitive compound, synaptoplastic compound, neurotrophic compound
CAS Number 1270138-41-4
Molecular Formula C₂₂H₃₃N₄O₅P
Molecular Weight 464.495 g/mol; 464.5 MW
Molecular Formula (Salt) C₂₂H₃₀N₄O·H₃O₄P
Optical Activity NONE
Charge 0
Primary Target Mechanism Phosphate salt of NSI-189; benzylpiperizine-aminiopyridine novel chemical entity; neurogenic small molecule; stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro; stimulates neurogenesis in murine hippocampus in vivo; regionally specific effects largely in subventricular zone of hippocampus; promotes proliferation and differentiation of neural stem/progenitor cells; increases hippocampal volume; antidepressant effects (non-monoamine based) mitigating depressive symptoms and improving cognitive function in adults with DSM-5-defined Major Depressive Disorder (MDD); novel multi-domain neurogenic compound with brain-therapeutic properties; potential therapeutic applications across disparate psychiatric disorders: depression, bipolar depression, cognition; procognitive effects; synaptoplastic effects; neurotrophic effects; phase 1b clinical trial (placebo-controlled double-blind, 24 MDD patients, 28 days, 40mg/80mg/120mg per day, 40mg one time dose, some once daily, some twice, some three times daily) showed over-round positive changes during drug period and follow up days; no side effects at lower doses; no significant improvement at 120mg/day; half-life: ~20 hours; typical dose: 40-120 mg/day; optimal: 40mg once or twice daily for 28 days; phase 2 study evaluating oral NSI-189 phosphate as monotherapy in major depressive disorder; 40mg 3 times/day multiple oral highest studied dose; developed by Neuralstem for treatment of cognitive disorders; now tested in phase II clinical trials in patients suffering from major depressive disorder; exact target molecule still unknown; new antidepressant and cognitive booster; good for low mood, students, athletes, fatigue
Physical Form White crystalline powder; solid
Purity 99.95% (May vary between batches)
Solubility Soluble in DMSO; soluble
Storage Condition Cool dry place; minimize contact with open air; store container tightly closed in dry, cool place

Research Applications & Storage Protocols

Multi-Domain Neurogenic Compound with Hippocampal Neurogenesis and Antidepressant Profile

NSI-189 Phosphate functions as the phosphate salt of NSI-189, a benzylpiperizine-aminiopyridine novel chemical entity developed by Neuralstem for treatment of cognitive disorders and major depressive disorder, that stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro and stimulates neurogenesis in murine hippocampus in vivo with regionally specific effects observed largely in subventricular zone of hippocampus. The compound demonstrates neurogenic small molecule that promotes proliferation and differentiation of neural stem/progenitor cells, increases hippocampal volume, exhibits antidepressant effects (non-monoamine based) mitigating depressive symptoms and improving cognitive function in adults with DSM-5-defined Major Depressive Disorder (MDD), is novel multi-domain neurogenic compound with brain-therapeutic properties with potential therapeutic applications across disparate psychiatric disorders including depression, bipolar depression, and cognition, has procognitive effects, synaptoplastic effects, and neurotrophic effects, was studied in phase 1b placebo-controlled double-blind trial in 24 MDD patients for 28 days using 40mg/80mg/120mg per day (40mg one time dose, frequency varies: once daily, twice daily, three times daily) showing over-round positive changes during drug taken period and in follow up days with no side effects at lower doses but no significant improvement at 120mg/day, has half-life of approximately 20 hours with typical dose 40-120 mg/day and optimal 40mg once or twice daily for 28 days, and is undergoing phase 2 study evaluating oral NSI-189 phosphate as monotherapy in major depressive disorder (40mg once daily), making it valuable for investigators studying neurogenesis stimulation, antidepressant research, major depressive disorder, multi-domain psychiatric disorders, neurotrophic pathway modulation, hippocampal volume enhancement, cognition improvement, procognitive effects, synaptoplastic effects, and neurogenic small molecule pharmacology in in vitro and in vivo experimental models.

Handling & Storage Guidelines

  • Long-Term Storage: Store in cool dry place, tightly sealed, away from heat, light and moisture; minimize contact with open air; crystalline powder stable in cool dry place; store container tightly closed in dry, cool place

  • Solubility: Soluble in DMSO; white crystalline powder appearance

  • Appearance: White crystalline powder, solid form

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. Always consult with a healthcare professional before starting any new supplement or research product. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.

Additional information
pa_feature

Discountinued

pa_form

Powders

pa_types

SARMs

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “NSI-189 Phosphate – Powder, 1g”